Thank you for visiting our website. Our office is beginning to reopen, although our home office in San Bernardino is not fully staffed. The home office is open Monday – Thursday each week, and some Fridays We have employees working from home to answer your questions and our Consultants are available, as always. We are still conducting live webinars; please check the listings for dates and times. Please contact us at or leave a voicemail at (800) 399-6565. We will respond to your inquiries as soon as possible.

Reimbursement for Corneal Collagen Cross-Linking

Corneal collagen cross-linking (CXL) uses a combination of riboflavin (vitamin B2) and ultraviolet (UVA) light to make collagen in the corneal stroma stronger and more flexible. In keratoconus and corneal ectasia, the corneal stroma has weakened, the cornea thins and bulges out, distorting vision. In most cases, CXL is ideally performed early in the disease process before vision deteriorates to the point where glasses or contact lenses no longer correct vision.

This FAQ addresses the following:

  1. What is corneal collagen cross-linking?
  2. What is involved in the CXL procedure?
  3. What conditions are treated with CXL?
  4. Has CXL been approved by the FDA?
  5. What CPT code should be used to report CXL?
  6. Is riboflavin (B2) separately reported on a claim for reimbursement?
  7. Is CXL covered by health insurance?
  8. What is the global period for 0402T?
  9. If coverage of CXL is unlikely or uncertain, how should we proceed?

Purchase This Resource:

Price: $33.00

Purchase the FAQ Library:

Price: $400.00

For best results, please view in Mozilla Firefox.

Website by MIC